13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)

A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);

(h)

A savings association as defined in Section 3(b) of
the Federal Deposit Insurance Act;

A church plan that is excluded from the definition
of an investment company under Section 3(c)(14) of the Investment Company Act;

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

Deerfield
Mgmt, L.P. – 3,420,193 shares

Deerfield Management Company,
L.P. – 3,420,193 shares

Deerfield Partners, L.P. –
1,336,816 shares

Deerfield International Master
Fund, L.P. – 1,708,367 shares

Deerfield
Special Situations Fund, L.P. – 375,010 shares

James E. Flynn – 3,420,193 shares

Deerfield
Mgmt, L.P. – 4.25%

Deerfield Management Company,
L.P. – 4.25%

Deerfield Partners, L.P. –
1.66%

Deerfield International Master
Fund, L.P. – 2.12%

Deerfield
Special Situations Fund, L.P. – 0.47%

James E. Flynn – 4.25%

Deerfield Mgmt, L.P. – 3,420,193

Deerfield Management Company, L.P. – 3,420,193

Deerfield Partners, L.P. – 1,336,816

Deerfield International Master Fund, L.P. – 1,708,367

Deerfield Special Situations Fund, L.P. –
375,010

James
E. Flynn – 3,420,193

Sole power to dispose or to direct the disposition of:

Shared power to dispose or to direct the disposition
of:

Deerfield Mgmt, L.P. – 3,420,193

Deerfield Management Company, L.P. – 3,420,193

Deerfield Partners, L.P. – 1,336,816

Deerfield International Master Fund, L.P. – 1,708,367

Deerfield Special Situations Fund, L.P. –
375,010

James
E. Flynn – 3,420,193